Enhabit Inc(EHAB) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.08 | Insider Own | 13.14% | Shs Outstand | 51.2M | Perf Week | - |
| Market Cap | 0.71B | Forward P/E | 22.62 | EPS next Y | 25.77% | Insider Trans | -0.1% | Shs Float | 46.4M | Perf Month | 0.36% |
| Enterprise Value | 1.17B | PEG | - | EPS next Q | 0.11 | Inst Own | 92.04% | Short Float | 0.3% | Perf Quarter | 1.47% |
| Income | -0.00B | P/S | 0.66 | EPS this Y | -8.49% | Inst Trans | -14.49% | Short Ratio | 0.08 | Perf Half Y | 58.26% |
| Sales | 1.06B | P/B | 1.28 | EPS next 5Y | -0.95% | ROA | -0.27% | Short Interest | 0.14M | Perf YTD | 49.67% |
| Book/sh | 10.81 | P/C | 13.73 | EPS past 3/5Y | 51.75% - | ROE | -0.58% | 52W High | -2.95% ($14.22) | Perf Year | 30.43% |
| Cash/sh | 1.01 | P/FCF | 8.74 | Sales past 3/5Y | -0.35% -0.34% | ROIC | -0.32% | 52W Low | 113.29% ($6.47) | Perf 3Y | 12.93% |
| Dividend Est. | - | EV/EBITDA | 11.9 | EPS Y/Y TTM | 97.59% | Gross Margin | 46.94% | Volatility(W/M) | 0.15% 0.16% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.09 | Sales Y/Y TTM | 3.16% | Oper. Margin | 7.25% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.56 | EPS Q/Q | 3.6% | Profit Margin | -0.3% | RSI (14) | 61.67 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.56 | Sales Q/Q | 1.89% | SMA20 | 0.34% ($13.75) | Beta | 0.94 | Target Price | $13.8 |
| Payout | - | Debt/Eq | 0.87 | Earnings | 2026/5/7 | SMA50 | 0.27% ($13.76) | Rel Volume | 0 | Prev Close | $13.8 |
| Employees | 10800 | LT Debt/Eq | 0.8 | EPS/Sales Surpr. | -4.58% -0.7% | SMA200 | 34.44% ($10.26) | Avg Volume(3M) | 1.65M | Price | $13.8 |
| IPO | 2022/6/23 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
Company
EHAB is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Enhabit (EHAB) is a U.S. home-based healthcare services company operating two core segments: Medicare-certified home health (visiting nursing) and hospice. Through a network of locations across multiple U.S. states, the company helps patients receive clinical care in the comfort of their own homes. It is a specialized home healthcare provider that was spun off from Encompass Health in 2022 and listed as an independent publicly traded company.
Over the past 1 year, on the higher side
3% below its 1-year high.
EHAB has weak earning power
7.25% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -8.5% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Would have changed by +12.9% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 92.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
NTRL 0.03%
MARB 0.03%
EVNT 0.01%
CSD 0.01%
SVAL 0.01%It ranks #4 in the industry
Based on market cap of $707M.
EHAB $707M PER -
HCA $92B PER 14.3
THC $21B PER 10.2
FMS $12B PER 11.8
FAQ
What kind of company is EHAB?
EHAB belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of EHAB?
The market cap of EHAB is approximately $707M, ranking 2,918 within its sector.
What is the 52-week high and low for EHAB?
EHAB has recorded a 52-week high of $14.22 and a low of $6.47.
